Co-Diagnostics, Inc. (CODX)
NASDAQ: CODX · Real-Time Price · USD
1.090
-0.030 (-2.68%)
Oct 8, 2026, 11:19 AM EDT - Market open
Co-Diagnostics Financials Overview
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 0.72 | 0.62 | 3.92 | 6.81 | 34.22 | 97.89 |
Revenue Growth | -28.12% | -84.10% | -42.53% | -80.09% | -65.04% | 31.30% |
Gross Profit Gross Profit Growth | 0.31 | 0.4 | 2.92 | 2.63 | 28.74 | 86.31 |
Operating Income Operating Income Growth | -30.08 | -31.28 | -40.08 | -42.71 | -11.59 | 46.06 |
Net Income Net Income Growth | -47.06 | -46.9 | -37.64 | -35.33 | -14.24 | 36.66 |
Earnings Per Share EPS Growth | -19.36 | -35.25 | -37.22 | -36.12 | -13.57 | 36.90 |
EPS Growth | - | - | - | - | - | -19.08% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
United States United States Growth | 0.56 | 0.58 | 3.52 | 6.48 | 24.67 | 52.19 |
Rest of World Rest of World Growth | 0.16 | 0.04 | 0.39 | 0.33 | 9.55 | 45.7 |
Total Total Growth | 0.72 | 0.62 | 3.92 | 6.81 | 34.22 | 97.89 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 3.65 | 11.88 | 29.75 | 58.55 | 81.26 | 89.86 |
Total Debt Total Debt Growth | 1.8 | 1.24 | 2.15 | 2.99 | 0.35 | - |
Net Cash (Debt) Net Cash Growth | 1.85 | 10.65 | 27.6 | 55.56 | 80.91 | 89.86 |
Net Cash Growth | -84.13% | -61.41% | -50.33% | -31.34% | -9.96% | 89.94% |
Net Cash Per Share Net Cash Per Share Growth | 0.76 | 8.00 | 27.29 | 56.79 | 77.11 | 90.15 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | -27.1 | -29.14 | -29.16 | -22.08 | 6.57 | 41.08 |
Capital Expenditures CapEx Growth | -0.37 | -0.7 | -0.75 | -1.37 | -1.43 | -0.67 |
Free Cash Flow Free Cash Flow Growth | -27.47 | -29.84 | -29.9 | -23.45 | 5.14 | 40.41 |
Free Cash Flow Growth | - | - | - | - | -87.28% | 47.54% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 43.48% | 64.28% | 74.48% | 38.56% | 83.98% | 88.17% |
Operating Margin | -4170.14% | -5025.53% | -1023.75% | -626.92% | -33.88% | 47.06% |
Pretax Margin | -6747.70% | -7793.22% | -959.90% | -559.46% | -55.08% | 46.62% |
Profit Margin | -6523.05% | -7533.62% | -961.37% | -518.68% | -41.61% | 37.45% |
FCF Margin | -3808.03% | -4793.17% | -763.79% | -344.20% | 15.02% | 41.28% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Oct '26 Oct 8, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | - | - | - | - | 7.10 |
Forward PE | - | 47.18 | 47.18 | 47.18 | 47.18 | 26.93 |
P/FCF Ratio | - | - | - | - | 15.16 | 6.44 |
PS Ratio | 9.71 | 16.49 | 6.12 | 5.97 | 2.28 | 2.66 |